|
MechanismPDE4B inhibitors |
|
|
|
Inactive Indication- |
Drug Highest PhasePhase 2 |
First Approval Ctry. / Loc.- |
First Approval Date- |
Target- |
Mechanism- |
|
|
Active Indication- |
Inactive Indication- |
Drug Highest PhaseIND Application |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Shanghai Haisishengnuo Pharmaceutical Technology Co., Ltd
0 Patents (Medical) associated with Shanghai Haisishengnuo Pharmaceutical Technology Co., Ltd
100 Deals associated with Shanghai Haisishengnuo Pharmaceutical Technology Co., Ltd
100 Translational Medicine associated with Shanghai Haisishengnuo Pharmaceutical Technology Co., Ltd